ãçè·åž«ã解説ããäœã®ç³åãã£ãŠäœïŒèåãçæŽ»ç¿æ £ç ãšã©ãé¢ä¿ããïŒä»æ¥ããã§ããç³å察ç
ããã«ã¡ã¯ã
çŸåœ¹çè·åž«ã®å¥åº·ããã°ãžããããã
ãç³åïŒãšããïŒã£ãŠèããããšã¯ããããã©ãããåãããªãã
ãç³åãããšèåãé²ãã£ãŠæ¬åœïŒã
ãçããã®ãé£ã¹ããšäœãç³åããã®ïŒã
çŸå®¹ãå¥åº·ã®è©±é¡ã§ãæè¿ããè³ã«ããããã«ãªã£ããç³åãã
å®ã¯ç³åã¯ãåãªãçŸå®¹äžã®åé¡ã§ã¯ãããŸããã
ç§ãã¡ã®äœã®äžã§ç³åãé²ããšãAGEsïŒæçµç³åç£ç©ïŒãšåŒã°ããç©è³ªãã€ããããè¡ç®¡ãããŸããŸãªçµç¹ã«åœ±é¿ãåãŒãããšãåãã£ãŠããŸãã
ä»åã¯ãçè·åž«ã®èŠç¹ãããäœã®ç³åãã«ã€ããŠãã§ããã ãåããããã解説ããŸãã

ãããããç³åãã£ãŠäœïŒ
ç³åãšã¯ãç°¡åã«ãããšã
äœã®äžã§äœã£ãç³ããã¿ã³ãã¯è³ªãè質ãªã©ãšçµã³ã€ããŠå€åããåå¿
ã®ããšã§ãã
ãã®åå¿ãé²ããšãæçµçã«ãAGEsïŒAdvanced Glycation End ProductsïŒæçµç³åç£ç©ïŒããšåŒã°ããç©è³ªãçããŸãã
AGEsã¯ãç³å°¿ç ãå 霢ã«äŒŽãããŸããŸãªå€åãšã®é¢é£ãç ç©¶ãããŠããŸãã
ã€ã¡ãŒãžãããšã
ç³ãäœã
â
äœã®ã¿ã³ãã¯è³ªãªã©ãšçµã³ã€ã
â
ç³ååå¿ãé²ã
â
AGEsãã§ãã
â
é
žåã¹ãã¬ã¹ãççãªã©ãä»ããŠãçµç¹ã«åœ±é¿ãã
ãšããæµãã§ãã

ãç³åïŒçããã®ãé£ã¹ããèµ·ãããã¯å°ãéã
ããã¯éèŠãªãã€ã³ãã§ãã
ç³åã¯ãçããã®ãé£ã¹ãç¬éã«äœããçŠããããšããåçŽãªè©±ã§ã¯ãããŸããã
äœå ã§ã¯è¡æ¶²äžã®ãããŠç³ãªã©ãé¢ä¿ããŠãæéããããŠç³ååå¿ãèµ·ãããŸãã
ç¹ã«ãè¡ç³å€ãé«ãç¶æ ãé·ãç¶ãããšã¯AGEsã®èç©ãšæ·±ãé¢ä¿ããŠããŸããç³å°¿ç ã§ã¯AGEsãå¢å ããç³å°¿ç å䜵çãšã®é¢é£ãææãããŠããŸãã
ã€ãŸãã
ãçããã®ã1åé£ã¹ãããç³åããŠããŸã£ãïŒã
ãšå¿ èŠä»¥äžã«å¿é ããå¿ èŠã¯ãããŸããã
ããã倧åãªã®ã¯ã
æ¥åžžçã«è¡ç³å€ãé«ããªããããçæŽ»ãç¶ããªãããš
ã§ãã

AGEsã¯äœã«ã©ããªåœ±é¿ãäžããã®ïŒ
AGEsãæ³šç®ãããŠããçç±ã®äžã€ããäœã®çµç¹ã«åœ±é¿ããå¯èœæ§ãããããã§ãã
äŸãã°ãAGEsã¯ã³ã©ãŒã²ã³ãªã©ã®é·å¯¿åœã¿ã³ãã¯è³ªãšçµã³ã€ããçµç¹ã®æ§è³ªãå€åãããããšããããŸãã
ãŸãAGEsãç¹å®ã®å容äœãšçµåãããšãé žåã¹ãã¬ã¹ãççã«é¢ä¿ããã·ã°ãã«ã掻æ§åãããããšãå ±åãããŠããŸãã
ç³å°¿ç ã§ã¯ãAGEsã
ã»è¡ç®¡é害
ã»è
ç
ã»ç¥çµé害
ã»ç¶²èç
ãªã©ã®å䜵çã«é¢ä¿ãããšèããããŠããŸãã
ãã®ãããç³åãã¯ãçŸå®¹ã ãã§ã¯ãªããè¡ç®¡ãèåšã®å¥åº·ãèããããã§ãéèŠãªããŒããªã®ã§ãã

ãç³åããšãé žåãã¯ã©ãéãïŒ
å¥åº·æ å ±ã§ããç»å Žãããç³åããšãé žåãã
䌌ããããªèšèã§ãããåããã®ã§ã¯ãããŸããã
é žå
掻æ§é žçŽ ãªã©ã«ãã£ãŠçްèãçµç¹ããã¡ãŒãžãåããç¶æ ã
ç³å
ç³ãšã¿ã³ãã¯è³ªãªã©ãéé µçŽ çã«åå¿ããAGEsãªã©ãçããåå¿ã
ãããŠããã®2ã€ã¯å®å šã«ç¬ç«ããŠããããã§ã¯ãããŸããã
ç³ååå¿ãé²ãéçšã§ã¯é žåã¹ãã¬ã¹ãé¢ä¿ããAGEsãšãã®å容äœã®åå¿ãé žåã¹ãã¬ã¹ãççã«ã€ãªããããšãç ç©¶ãããŠããŸãã
ã€ãŸãã
ç³åãšé žåã¯ãäºãã«é¢é£ããªããäœãžã®è² æ ã«é¢ä¿ãã
ãšèãããšåãããããã§ãããã

é£ã¹ç©ãããAGEsã¯å ¥ã£ãŠããïŒ
AGEsã¯äœå ã§ã€ããããã ãã§ã¯ãããŸããã
é£åãå ç±ããéçšã§ãAGEsã圢æãããããšããããŸãã
ç¹ã«ã
æããã»çŒãã»çããã»çŽç«ã§å ç±ãã
ãªã©ãæ¯èŒç髿ž©ã§ä¹Ÿç¥ããå ç±èª¿çã§ã¯AGEsãçæãããããããšãç¥ãããŠããŸãã
äŸãã°ã
ã»æãç©
ã»çŒãè
ã»ããããçŒããé£å
ã»çŒãèå
ãªã©ã¯ãAGEsã®èгç¹ããã¯ãèª¿çæ¹æ³ããèããäœå°ããããŸãã
ãã ãã
ãçŒããé£åã¯é£ã¹ãŠã¯ãããªãã
ãšããæå³ã§ã¯ãããŸããã
é£äºå šäœã®ãã©ã³ã¹ãèããªãããèª¿çæ¹æ³ã工倫ããããšã倧åã§ãã

ç³åãé²ãããã«ãäœãããã°ããïŒ
ããã§å€§åãªã®ã¯ã
ãç³åãå®å šã«é²ããããšã§ã¯ãªããç³åã«ã€ãªããçæŽ»ç¿æ £ãæžãããŠããããš
ã§ãã
â çã飲ã¿ç©ãç¿æ £ã«ããªã
ç³åãå€ãå«ã飲æãé »ç¹ã«é£²ãç¿æ £ã¯ãè¡ç³å€ãç³å°¿ç ãªã¹ã¯ã®èгç¹ãããæ³šæãå¿ èŠã§ãã
æ°Žããè¶ãªã©ãåºæ¬ã«ããŠãçã飲æã¯ãæ¯æ¥ã®æ°Žåè£çµŠãã§ã¯ãªããæ¥œãã¿ãšããŠèããã®ãäžã€ã®æ¹æ³ã§ãã
åçåŽåçãç³å°¿ç äºé²ã®èгç¹ãããç ç³å ¥ã飲æã®ãšãããã«æ³šæãä¿ããŠããŸãã
â¡ ãç³è³ªãŒããã ããç®æããªã
ç³åãæ°ã«ãªããããšãã£ãŠã
ãç³è³ªã¯å šéšæªãïŒã
ãšèããå¿ èŠã¯ãããŸããã
ç³è³ªã¯äœãåãããšãã«ã®ãŒæºã§ããããŸãã
æ¥æ¬ç³å°¿ç åŠäŒããç¹å®ã®æ é€çŽ ã ããæ¥µç«¯ã«å¶éããã®ã§ã¯ãªãã驿£ãªãšãã«ã®ãŒéãšãã©ã³ã¹ã®ããé£äºãåºæ¬ãšããŠããŸãã
倧åãªã®ã¯ã
éã»çµã¿åããã»é£ã¹æ¹
ã§ãã
⢠éèã倧è±è£œåãæµ·è»ããã®ããªã©ãåãå ¥ãã
é£äºã§ã¯ã
ã»éè
ã»å€§è±è£œå
ã»æµ·è»
ã»ãã®ãé¡
ãªã©ãåãå ¥ããé£äºå šäœã®ãã©ã³ã¹ãæŽããŸãããã
åçåŽåçãç³å°¿ç äºé²ã®é£ç掻ãšããŠããããã®é£åãå€ããšãããšãªã©ãæããŠããŸãã
⣠ãé£ã¹ãªãããããé£ã¹æ¹ããèãã
ç³å察çãšãããšã
ãäœãé£ã¹ãªããã
ã°ããã«ç®ãåããã¡ã§ãã
ããããå¥åº·çãªé£ç掻ã§ã¯ã
äœããã©ãããããã©ã®ããã«é£ã¹ãã
ãéèŠã§ãã
äž»é£ã ãã«åãããäž»èãå¯èãçµã¿åããããªã©ããã©ã³ã¹ãæèããŸãããã
†äœãåãã
ç³å察çãèããããã§ãç§ãçè·åž«ãšããŠç¹ã«ãããããããã®ããéåãã§ãã
ãªããªãéåã¯ãç³åã ããçã£ããã®ã§ã¯ãªãã
è¡ç³ã³ã³ãããŒã«
ã€ã³ã¹ãªã³ã®å¹ãããã
è質代è¬
è¡å§
äœå
ãªã©ãå¥åº·å šäœã«ã¡ãªãããããããã§ãã
åçåŽåçã®e-ãã«ã¹ãããã§ã¯ãç³å°¿ç ã®éåçæ³ãšããŠãäžçåºŠã®æé žçŽ éåãé±150å以äžãé±3å以äžè¡ãããšãªã©ãäžè¬çã«æšå¥šãããŠããŸãããŸããã¬ãžã¹ã¿ã³ã¹éåãé±2ïœ3åçµã¿åãããããšãå§ããããŠããŸãã
ãã ããããã¯ãã¹ãŠã®äººã«ãã®ãŸãŸåœãŠã¯ãŸãããã§ã¯ãããŸããã
æç ãããæ¹ãæ²»çäžã®æ¹ãé«éœ¢ã®æ¹ãªã©ã¯ãç¡çãããå»çè ã«çžè«ããŠãã ããã
⥠ãé£åŸã«å°ãåããããšãéžæè¢
éåã¯ã
ããžã ã«è¡ããªããã°æå³ããªãã
ããã§ã¯ãããŸããã
æ©ããéæ®µã䜿ããè²·ãç©ã«è¡ããªã©ãæ¥åžžç掻ã®äžã§èº«äœæŽ»åãå¢ããããšã倧åã§ãã
åçåŽåçã®æ å ±ã§ã¯ãé£åŸã®éåã«ãã£ãŠé£åŸã®é«è¡ç³ç¶æ ãæ¹åãããããšã玹ä»ãããŠããŸãã
äŸãã°ã
ãå€é£åŸã«10ïœ20åçšåºŠæ©ãã
ãªã©ãç¡çãªãç¶ããããæ¹æ³ããå§ããã®ãããã§ãããã
⊠å¥èšºã®ãè¡ç³å€ããæŸçœ®ããªã
çè·åž«ãšããŠãããã¯ãã²äŒããããã€ã³ãã§ãã
ç³åãæ°ã«ãªã£ãŠã
ãæç³åé£åãæ¢ãã
ããšãããã
å¥èšºã§è¡ç³å€ãHbA1cã確èªããããš
ã®ã»ãããå¥åº·ç®¡çãšããŠéèŠã§ãã
åçåŽåçã«ãããšãç©ºè ¹æè¡ç³126mg/dL以äžãéæè¡ç³200mg/dL以äžãHbA1c6.5ïŒ ä»¥äžãªã©ã確èªãããå Žåãç³å°¿ç ã§ããå¯èœæ§ãé«ããå»çæ©é¢ã§ã®æ€æ»ãå¿ èŠã§ãã
ãã¡ããããããã®æ°å€ã ãã§èªå·±å€æãããã®ã§ã¯ãããŸããã
ãå¥èšºã§è¡ç³å€ãé«ãã£ãã
ãHbA1cã以åããäžãã£ãŠããã
ãšããå Žåã«ã¯ãæŸçœ®ããå»çæ©é¢ã«çžè«ããŸãããã
ãç³å察çïŒè¥è¿ããã§ã¯ãªã
ãããæ³šæããããšããã§ãã
ã€ã³ã¿ãŒãããã§ã¯ã
ãç³åãé²ãã°è¥è¿ãã
ãAGEsãæžããã°ã·ã¯ãæ¶ããã
ãªã©ãããªã匷ã衚çŸãèŠãããããšããããŸãã
ããããAGEsã¯èåãç³å°¿ç ãªã©ãšã®é¢é£ãç ç©¶ãããŠããäžæ¹ã§ãç³åãæžããã°å¿ ãèŠãç®ãè¥è¿ãããšåçŽã«æèšã§ããããã§ã¯ãããŸããã
é£äºç±æ¥AGEsã«ã€ããŠãã人ãžã®å¥åº·åœ±é¿ãäœå ã§ã®å¯äžã«ã€ããŠã¯ããŸã ç ç©¶ãç¶ããŠããŸãã
ãã®ããã
ãAGEsãå®å šã«ãŒãã«ãããïŒã
ãšæ¥µç«¯ã«ãªãå¿ èŠã¯ãããŸããã
çè·åž«ããäŒããããç³å察çãã®æ¬åœã®ãã€ã³ã
ç³å察çãšãããšã
ãçããã®çŠæ¢ïŒã
ãæãç©çŠæ¢ïŒã
ãç³è³ªå¶éïŒã
ãšå³ããèããŠããŸããã¡ã§ãã
ã§ããå¥åº·ã¥ããã§å€§åãªã®ã¯ã極端ãªå¶éã§ã¯ãããŸããã
仿¥ããã§ããããš
â çã飲ã¿ç©ãç¿æ £ã«ããªã
â¡ é£äºã¯ãã©ã³ã¹ãæèãã
⢠éèã»å€§è±è£œåã»æµ·è»ã»ãã®ããªã©ãåãå ¥ãã
⣠æãç©ãçŒãç©ã°ããã«åããªã
†æ¥åžžç掻ã§äœãåãã
⥠å¥èšºã®è¡ç³å€ã»HbA1cã確èªãã
⊠ç°åžžå€ãããã°å»çæ©é¢ã«çžè«ãã
ãã®ãããããå§ããŠååã§ãã
ãŸãšã
ãç³åãã¯ãåãªãçŸå®¹çšèªã§ã¯ãããŸããã
äœå ã§ç³ååå¿ãé²ããšAGEsã圢æãããè¡ç®¡ãçµç¹ã®å€åãç³å°¿ç å䜵çãªã©ãšã®é¢é£ãç ç©¶ãããŠããŸãã
äžæ¹ã§ã
ãç³åïŒèåã®ãã¹ãŠã
ã§ã¯ãããŸããã
幎霢ãéºäŒãè¡ç³å€ãè¡å§ãè質ãå«ç ãéåäžè¶³ãç¡ç ãªã©ãå¥åº·ã«ã¯ããŸããŸãªèŠå ãé¢ä¿ããŸãã
ã ããããã
ãç³åãæãããã®ã§ã¯ãªãããè¡ç³å€ãé«ããªãã«ããçæŽ»ãã€ããã
ãšããèŠç¹ã倧åã§ãã
çè·åž«ãšããŠãããããããã®ã¯ãç¹å¥ãªãæç³åé£åããæ¢ãããšããå§ããã®ã§ã¯ãªãã
ãã©ã³ã¹ã®ããé£äºïŒé©åºŠãªéåïŒå¥èšºçµæã®ç¢ºèª
ãšãããæããèšãããŠããåºæ¬çãªå¥åº·ç¿æ £ã§ãã
äœã®ç³åãèããããšã¯ãå®ã¯ãè¡ç®¡ãšçæŽ»ç¿æ £ç ãå®ãããšããèããããšã«ãã€ãªãããŸãã
ç¡çãªããã§ããããšããå§ããŠãããŸãããã
åèè³æã»ããã«è©³ããç¥ãããæ¹ãž
åçåŽåç e-ãã«ã¹ããããç³å°¿ç ãæ¹åããããã®éåã
æ¥æ¬ç³å°¿ç åŠäŒã2åç³å°¿ç ã¯ã©ã®ããã«æ²»çããã®ãïŒã
PubMedãAdvanced glycation end products, diabetes and ageingã
PubMedãAdvanced glycation endproducts in diabetes and diabetic complicationsã
PubMedãDietary advanced glycation end products and their relevance for human healthã
